-
Genome analyses track SARS-CoV-2's early introduction to the US and Europe
worldpharmanews
September 14, 2020
SARS-CoV-2 arrived in Washington State somewhere between late January and early February 2020, sparking rapid community transmission of the virus that went undetected for several weeks before this community spread became evident ...
-
Europe on high alert as Coronavirus (Covid-19) spread intensifies
pharmaceutical-technology
March 04, 2020
European countries are on high alert as coronavirus (Covid-19) is spreading rapidly across the region.
-
Medicine shortages should be an industry priority, EFPIA says
europeanpharmaceuticalreview
January 19, 2020
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has said that medicine shortages may negatively impact patient care and deserves serious action.
-
SpringWorks receives orphan status for nirogacestat in Europe
pharmaceutical-technology
September 27, 2019
US-based SpringWorks Therapeutics has received orphan drug designation from the European Commission (EC) for its small molecule candidate nirogacestat to treat soft tissue sarcoma.
-
WHO: 'Dramatic Resurgence' of Measles Occurring in Europe
drugs
August 30, 2019
Vaccine refusals have contributed to a "dramatic resurgence" of measles in Europe, the World Health Organization says.
-
Switzerland found to be most innovative drug delivery market in Europe
europeanpharmaceuticalreview
August 27, 2019
According to new research, innovation in drug delivery is accelerating in Europe, with Switzerland as Europe’s biggest drug delivery innovator.
-
Terrosa® osteoporosis biosimilar treatment launched in Europe
europeanpharmaceuticalreview
August 23, 2019
A new biosimilar drug to treat osteoporosis is now available across Europe after the patent for its reference product expired.
-
Generic Version of Navelbine® Softgel Capsule Launched in Europe
americanpharmaceuticalreview
August 02, 2019
Alvogen announced its subsidiary Lotus Pharmaceuticals has launched Vinorelbine 20, 30 and 80mg soft capsules in Europe. The product is the generic version of Pierre Fabre Médicament’s Navelbine®, which is indicated for the treatment of ...
-
Marken Acquires Three European Logistics Companies
contractpharma
July 16, 2019
Expands logistics footprint in Italy, Austria and Hungary .
-
ViiV Healthcare receives MA in Europe for Dovato
pharmaceutical-technology
July 04, 2019
The European Commission (EC) has approved ViiV Healthcare’s marketing authorisation application (MAA) for Dovato (dolutegravir/lamivudine), which is indicated to treat HIV-1 infection.